Lilly and Nektar Therapeutics announce alliance to develop a novel autoimmune therapy
Almac Discovery is Granted Orphan Drug Designation for ALM201 Programme in Ovarian Cancer
Fareva Excelvision completed a 30 mEUR+ investment in ophthalmics manufacturing capabilities
Catalent Launches New OptiForm® Solution Suite To Offer Quick And Efficient Path From Late-Stage Discovery To Phase I Clinical Trials
Gerresheimer will launch an innovative syringe safety solution through exclusive licence from West
To sign in, enter your username and password below
Forgot your password?
Tweets by MyPharmaPlace